Korean Stock Flows

Samjin Pharmaceutical (KRX: 005500)

삼진제약 KOSPI Biotech & Pharma 의약품 제조업
Close (Oct 16, 2026)
₩19,340
+1.26%
Market cap
₩0T ($0.2B)
52-week range
₩16,580 – ₩25,900
P/E (12M fwd) · P/B · Div yield
10.56 · 0.84 · 4.14%
trailing 9.85 · consensus of 1 analysts

Who is buying Samjin Pharmaceutical?

Between Sep 15, 2026 and Oct 16, 2026 (20 trading sessions), foreign investors net bought ₩0.6bn ($0M) of Samjin Pharmaceutical, the 158th largest foreign net purchase among 832 KOSPI stocks. Institutions net sold ₩0.1bn ($0M) and retail investors net sold ₩0.4bn ($0M) over the same window. Foreigners were net buyers on 11 of the 20 sessions.

Foreign investors hold 3.83% of Samjin Pharmaceutical's listed shares (KRX ownership data as of Oct 16, 2026), up from 3.76% twenty sessions earlier and 2.89% a year ago.

The stock closed at ₩19,340 on Oct 16, 2026: +4.26% over 20 sessions, -2.08% year-to-date, -1.73% over one year. The 52-week range is ₩16,580 – ₩25,900.

At ₩19,340 the stock trades at 10.56× 12-month-forward consensus earnings (1 analysts), 10.39× on FY2027 estimates. The trailing P/E published by KRX is 9.85×, based on the last completed fiscal year.

Samjin Pharmaceutical share price, last 60 trading days (KRW)
20,285 19,132 17,978 16,825 Jul 16 Aug 31 Oct 16
Daily foreign investor net purchases, last 60 trading days
+0.5bn +0.3bn -0.3bn -0.5bn Jul 16 Aug 31 Oct 16
View chart data as a table
Date Close Foreign net Institutions Retail
2026-10-16 ₩19,340 +₩0.1bn +₩0.0bn ₩-0.1bn
2026-10-15 ₩19,100 +₩0.5bn ₩-0.0bn ₩-0.5bn
2026-10-14 ₩19,640 +₩0.1bn +₩0.0bn ₩-0.1bn
2026-10-13 ₩19,900 ₩-0.1bn +₩0.0bn +₩0.1bn
2026-10-12 ₩20,100 ₩-0.1bn +₩0.0bn +₩0.1bn
2026-10-08 ₩20,100 ₩-0.1bn ₩0.0bn +₩0.1bn
2026-10-07 ₩19,820 +₩0.1bn ₩-0.0bn ₩-0.1bn
2026-10-06 ₩19,320 ₩-0.0bn ₩-0.0bn +₩0.0bn
2026-10-02 ₩19,080 ₩-0.2bn ₩-0.0bn +₩0.2bn
2026-10-01 ₩19,380 +₩0.1bn +₩0.0bn ₩-0.1bn
2026-09-30 ₩18,750 ₩-0.0bn ₩-0.0bn +₩0.0bn
2026-09-29 ₩18,730 ₩-0.0bn ₩-0.1bn +₩0.1bn
2026-09-28 ₩18,690 +₩0.2bn ₩-0.1bn ₩-0.2bn
2026-09-23 ₩18,450 +₩0.0bn ₩-0.0bn +₩0.0bn
2026-09-22 ₩18,460 +₩0.0bn +₩0.0bn ₩-0.1bn
2026-09-21 ₩18,480 +₩0.0bn ₩-0.0bn ₩-0.0bn
2026-09-18 ₩18,470 +₩0.0bn +₩0.0bn ₩-0.0bn
2026-09-17 ₩18,590 +₩0.1bn ₩-0.0bn ₩-0.1bn
2026-09-16 ₩18,550 ₩-0.1bn ₩-0.0bn +₩0.1bn
2026-09-15 ₩18,390 ₩-0.1bn +₩0.0bn +₩0.0bn
2026-09-14 ₩18,550 +₩0.1bn +₩0.0bn ₩-0.1bn
2026-09-11 ₩18,440 +₩0.1bn +₩0.0bn ₩-0.1bn
2026-09-10 ₩18,550 ₩-0.1bn ₩-0.0bn +₩0.2bn
2026-09-09 ₩18,670 +₩0.0bn +₩0.0bn ₩-0.0bn
2026-09-08 ₩18,710 +₩0.0bn ₩-0.0bn +₩0.0bn
2026-09-07 ₩18,780 +₩0.0bn ₩-0.0bn ₩-0.0bn
2026-09-04 ₩18,750 ₩-0.1bn +₩0.0bn +₩0.1bn
2026-09-03 ₩18,820 ₩-0.2bn ₩-0.0bn +₩0.2bn
2026-09-02 ₩18,660 ₩-0.3bn +₩0.0bn +₩0.2bn
2026-09-01 ₩18,820 +₩0.1bn +₩0.0bn +₩0.0bn
2026-08-31 ₩18,800 ₩-0.0bn ₩-0.0bn ₩-0.0bn
2026-08-28 ₩18,430 +₩0.1bn ₩-0.0bn ₩-0.1bn
2026-08-27 ₩18,330 ₩-0.2bn ₩-0.0bn +₩0.2bn
2026-08-26 ₩18,550 +₩0.3bn ₩-0.0bn ₩-0.3bn
2026-08-25 ₩18,060 +₩0.1bn ₩-0.0bn ₩-0.1bn
2026-08-24 ₩18,040 +₩0.1bn ₩-0.0bn ₩-0.1bn
2026-08-21 ₩17,800 ₩-0.3bn +₩0.0bn +₩0.2bn
2026-08-20 ₩18,020 +₩0.1bn ₩-0.0bn ₩-0.1bn
2026-08-19 ₩17,500 ₩-0.2bn +₩0.0bn +₩0.2bn
2026-08-18 ₩17,790 ₩-0.1bn +₩0.1bn +₩0.0bn
2026-08-14 ₩18,440 +₩0.3bn ₩-0.0bn ₩-0.2bn
2026-08-13 ₩18,270 ₩-0.3bn ₩-0.0bn +₩0.3bn
2026-08-12 ₩18,450 ₩-0.3bn ₩0.0bn +₩0.3bn
2026-08-11 ₩18,690 +₩0.3bn +₩0.0bn ₩-0.3bn
2026-08-10 ₩18,370 +₩0.3bn +₩0.0bn ₩-0.3bn
2026-08-07 ₩18,300 +₩0.1bn ₩-0.0bn ₩-0.1bn
2026-08-06 ₩18,190 +₩0.0bn +₩0.0bn ₩-0.0bn
2026-08-05 ₩18,250 +₩0.1bn ₩-0.0bn ₩-0.1bn
2026-08-04 ₩17,850 +₩0.1bn ₩-0.0bn ₩-0.1bn
2026-08-03 ₩17,650 ₩-0.1bn +₩0.0bn ₩-0.0bn
2026-07-31 ₩17,730 +₩0.2bn ₩-0.0bn ₩-0.2bn
2026-07-30 ₩17,060 +₩0.4bn +₩0.0bn ₩-0.4bn
2026-07-29 ₩17,010 ₩-0.0bn ₩-0.0bn +₩0.0bn
2026-07-28 ₩17,540 ₩-0.2bn ₩-0.0bn +₩0.2bn
2026-07-27 ₩17,920 ₩-0.0bn +₩0.0bn +₩0.0bn
2026-07-24 ₩17,870 +₩0.0bn +₩0.0bn ₩-0.0bn
2026-07-23 ₩17,880 +₩0.0bn +₩0.0bn ₩-0.0bn
2026-07-22 ₩17,580 ₩-0.3bn +₩0.0bn +₩0.2bn
2026-07-21 ₩17,750 +₩0.0bn +₩0.0bn ₩-0.0bn
2026-07-20 ₩17,500 ₩-0.2bn ₩-0.0bn +₩0.2bn
2026-07-16 ₩17,950 +₩0.0bn ₩-0.1bn +₩0.0bn

Investor flows summary

Window Foreign (USD) Institutions Retail
1 day +₩0.1bn +$0M +₩0.0bn ₩-0.1bn
5 days +₩0.5bn +$0M +₩0.0bn ₩-0.5bn
20 days +₩0.6bn +$0M ₩-0.1bn ₩-0.4bn

Positive = net buying, negative = net selling. Values aggregate the KRX main board and the NXT alternative venue.

Frequently asked questions

Are foreign investors buying Samjin Pharmaceutical stock?

Over the last 5 sessions foreign investors net bought ₩0.5bn ($0M) of Samjin Pharmaceutical; over 60 sessions they net bought ₩0.7bn ($1M); since Jan 1, 2026 they net sold ₩0.9bn ($1M). Over 20 sessions the stock is the 158th largest foreign net purchase among 832 KOSPI stocks.

How much of Samjin Pharmaceutical do foreign investors own?

Foreign investors own 3.83% of Samjin Pharmaceutical's shares as of Oct 16, 2026, versus 2.89% one year earlier. The figure is KRX's daily foreign holdings divided by listed shares, and it reflects trades settled through the previous session.

Who is on the other side — institutions or retail investors?

Over 20 sessions institutions net sold ₩0.1bn ($0M) and retail investors net sold ₩0.4bn ($0M) of Samjin Pharmaceutical. Foreign buying is being met mainly by retail selling.

Is Samjin Pharmaceutical listed on KOSPI or KOSDAQ?

Samjin Pharmaceutical (삼진제약) trades on KOSPI under KRX code 005500 in the Biotech & Pharma group, with a market capitalization of ₩0T ($0.2B). Daily net flows by investor type are published by KRX after each session and combine the KRX main board with the NXT venue.

Annual financials

Fiscal year Revenue YoY Operating profit Net income
2023 ₩292bn ($217M) – ₩20bn ($15M) ₩19bn ($14M)
2024 ₩308bn ($229M) +5.60% ₩32bn ($24M) ₩39bn ($29M)
2025 ₩309bn ($230M) +0.30% ₩27bn ($20M) ₩24bn ($18M)

Consolidated (K-IFRS) where available, from DART regulatory filings. USD figures converted at the current rate (₩1345.9/$) for reference only.

← All foreign investor flows